MOLN logo

Molecular Partners AG

MOLN
Healthcare|Biotechnology|CH
$3.14
-0.08 (-2.48%)
DCF Value
$2.61
Tangible Book / Share
$1.32
Cash / Share
$1.50
Next Earnings Report
Mar 11, 2027
EPS est. -$0.44
Financing Filings (last 12 months)
0
No shelf registrations or offering prospectuses filed.

Upcoming Data Readouts (2)

Sep 2028
Est. completion
P1P2Large Cell Neuroendocrine Carcinoma
Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
NCT07278479n=138
Nov 2028
Est. completion
P2Advanced Biliary Tract Carcinoma
MP0317 in Combination With Chemoimmunotherapy in First Line Treatment for Patients With Advanced Biliary Tract Carcinoma
NCT07036380n=75

Recent Press Releases

Molecular Partners Presents New Preclinical Data for Next-Generation T Cell Engager MP0632 at SITC 2026
Nov 6, 2026 · GlobeNewsWire
Molecular Partners to Present on DLL3-Targeting Radio-DARPin MP0712 at 2026 SNMMI Theranostics Conference and NACLC 2026
Nov 5, 2026 · GlobeNewsWire
Molecular Partners Reports Q3 2026 Financial Results, Deepens Focus on Targeted Radiotherapy
Oct 29, 2026 · GlobeNewsWire
Molecular Partners Reports H1 2026 Financial Results and Corporate Highlights: DLL3 Radiotherapy MP0712 Successfully Advancing to Higher Dose Level in Phase 1/2a Study
Aug 25, 2026 · GlobeNewsWire

SEC Filings (32)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 29, 20266-KForeign issuer reportDocumentIndex
Aug 25, 20266-KForeign issuer reportDocumentIndex
Jul 20, 20266-KForeign issuer reportDocumentIndex
Jul 7, 20266-KForeign issuer reportDocumentIndex
Jul 2, 20266-KForeign issuer reportDocumentIndex
Jun 24, 2026S-8Employee stock planDocumentIndex
Jun 1, 20266-KForeign issuer reportDocumentIndex
May 12, 20266-KForeign issuer reportDocumentIndex
May 1, 20266-KForeign issuer reportDocumentIndex
Apr 14, 20266-KForeign issuer reportDocumentIndex
Mar 30, 20266-KForeign issuer reportDocumentIndex
Mar 13, 20266-KForeign issuer reportDocumentIndex
Mar 12, 20266-KForeign issuer reportDocumentIndex
Mar 12, 202620-FAnnual report (foreign)DocumentIndex
Feb 2, 20266-KForeign issuer reportDocumentIndex
Jan 12, 20266-KForeign issuer reportDocumentIndex
Dec 8, 20256-KForeign issuer reportDocumentIndex
Nov 12, 20256-KForeign issuer reportDocumentIndex
Oct 30, 20256-KForeign issuer reportDocumentIndex
Aug 25, 20256-KForeign issuer reportDocumentIndex
Jul 17, 2025SC 13GPassive 5%+ stakeDocumentIndex
Jun 25, 2025S-8Employee stock planDocumentIndex
Jun 12, 20256-KForeign issuer reportDocumentIndex
May 15, 20256-KForeign issuer reportDocumentIndex
May 2, 2025SC 13GPassive 5%+ stakeDocumentIndex
Apr 29, 20256-KForeign issuer reportDocumentIndex
Apr 24, 2025EFFECTDocumentIndex
Mar 6, 20256-KForeign issuer reportDocumentIndex
Mar 6, 20256-KForeign issuer reportDocumentIndex
Mar 6, 202520-FAnnual report (foreign)DocumentIndex
Jan 13, 20256-KForeign issuer reportDocumentIndex
Jan 13, 20256-KForeign issuer reportDocumentIndex